News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
154 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17567)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Policy
Sobi Receives Approval From Health Canada for Orfadin (nitisinone) Oral Suspension for the Treatment of HT-1
Orfadin is the first medicine approved in multiple countries globally for use in combination with dietary restriction of tyrosine and phenylalanine in the treatment of hereditary tyrosinemia type 1 (HT-1).
November 27, 2017
·
3 min read
Business
Materialise and Siemens Healthineers syngo.via Partner to Bring 3D Printing to Hospitals Worldwide
The partnership makes Materialise Mimics inPrint software, a dedicated solution for printing anatomical models in hospitals, available to radiologists through the Siemens Healthineers syngo.via open app platform.
November 27, 2017
·
4 min read
Business
AstraZeneca Partners Up With Chinese Fund to Launch New Biopharma Company
The deal aims to accelerate local development of innovative medicines for patients in China and builds on AstraZeneca’s strong presence in the country.
November 27, 2017
·
4 min read
BioMidwest
3D Systems Extends Leadership in Precision Healthcare With Technology Advancements to Quickly Create 3D Models
The company also announced the industry-first Volume VR technology that allows physicians to upload patient scan data to D2P and immediately visualize medical datasets in virtual reality without time-consuming pre-processing or segmentation.
November 27, 2017
·
5 min read
FDA
IMRIS and Hill-Rom Announce FDA Clearance of New MRI-Conditional Surgical Table for Hybrid OR
The new surgical table system will be an essential component of the IMRIS Surgical Theatre - a suite of intraoperative imaging technologies that allow neurosurgeons to see critical anatomical detail during surgery, without moving the patient from the operating table.
November 27, 2017
·
4 min read
Lone Star Bio
Acelity: New Independent Study Results Add to Growing Body of Evidence That PREVENA Therapy Helps Reduce Surgical Site Infections and Complications
Study concludes that total arthroplasty patients treated with PREVENA Therapy were four times less likely to experience surgical site complications compared with traditional gauze dressing.
November 27, 2017
·
6 min read
Business
Microbix Confirms Ramp-Up of Production
Microbix’ revenues are mainly from sales of its antigens as critical components for makers of tests that diagnose infectious diseases.
November 27, 2017
·
4 min read
Can-Fite Reports Third Quarter 2017 Financial Results & Provides Clinical Update
Revenues for the nine months ended September 30, 2017 were NIS 2.61 million (U.S. $0.74 million) compared to NIS 0.64 million (U.S. $0.18 million) in the first nine months of 2016.
November 27, 2017
·
15 min read
Drug Development
Seoul National University Hospital Release: Ultraviolet Rays on Your Skin May Exacerbate Your Brain Function
The research team analyzed neurogenesis as well as the changes in synaptic proteins that connect neurons to neurons in the hippocampus of the brain after irradiating the mouse skin with UV for a total of 6 times over 2 weeks.
November 27, 2017
·
2 min read
Business
Intrexon Announces Key Management Appointments
Intrexon today announced key executive promotions.
November 27, 2017
·
6 min read
Previous
8 of 16
Next